Sign Up

Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: Results from a randomized controlled trial (Canada)

International Literature

posted by WM Admin on 26 June 2015

Location

International

The authors report that "adding pharmacists to primary care teams significantly improved blood pressure control and reduced predicted 10–year cardiovascular risk in patients with Type 2 diabetes". In this analysis, they evaluated the economic implications of the strategy.

The authors conclude from the results of their analysis that "... adding pharmacists to primary care teams was a cost-effective strategy for reducing cardiovascular risk in patients with Type 2 diabetes. In most circumstances, this intervention may also be cost saving".

To read the full abstract, and for information on how to access the full text, go to:http://dx.doi.org/10.1111/dme.12692 or contact your DHB library, or organisational or local library for assistance.

Simpson, S.H., et al. (2015). Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: Results from a randomized controlled trial. Diabetic Medicine, 32899906